After covid19 vaccine. We are going to be talking in particular of an Innovative New model to try to address the issues around how to encourage accelerated research and development of important vaccine candidates, but also, how they can produced and distributed in ways that take an International Perspective and a perspective of equity and a Public Healthdriven distribution approach. So, were going to be talking a lot about the covax and theres a slide for the audience to get more grounded in what is covax. Its the vaccine pillar of something called the act accelerator to speed up access to diagnostics, therapeutics and vaccines. There are three elements of the necessary tools for an effective medical and Public Health response. This was launched in april and it was really launched as a collaboration of both government, importantly including the European Union and their president , but also philanthropy and not for profit organizations coming together, recognizing this critical need as